Janney Capital Management LLC Sage Therapeutics, Inc. Transaction History

Janney Capital Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 01, 2021	SELL	$40.26 - $57.37 $257,221 - $366,536	-6,389 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$54.88 - $79.29 $1,481 - $2,140	27 Added 0.42%	6,389 $363,000
Q1 2021 Apr 27, 2021	BUY	$70.65 - $96.76 $2,260 - $3,096	32 Added 0.51%	6,362 $476,000
Q4 2020 Jan 25, 2021	SELL	$58.41 - $89.06 $2,862 - $4,363	-49 Reduced 0.77%	6,330 $548,000
Q3 2020 Nov 06, 2020	BUY	$41.13 - $62.45 $262,368 - $398,368	6,379 New	6,379 $390,000
Q4 2019 Jan 21, 2020	SELL	$60.18 - $154.77 $256,065 - $658,546	-4,255 Closed	0 $0
Q3 2019 Oct 28, 2019	SELL	$140.29 - $189.96 $18,518 - $25,074	-132 Reduced 3.01%	4,255 $597,000
Q2 2019 Jul 29, 2019	BUY	$157.85 - $183.09 $106,548 - $123,585	675 Added 18.18%	4,387 $803,000
Q1 2019 Apr 30, 2019	BUY	$89.33 - $163.65 $27,602 - $50,567	309 Added 9.08%	3,712 $590,000
Q4 2018 Feb 01, 2019	BUY	$81.94 - $139.71 $45,722 - $77,958	558 Added 19.61%	3,403 $326,000
Q3 2018 Jan 04, 2019	SELL	$138.11 - $169.04 $409,081 - $500,696	-2,962 Reduced 51.01%	2,845 $402,000
Q3 2018 Nov 14, 2018	BUY	$138.11 - $169.04 $802,004 - $981,615	5,807 New	5,807 $0

217

48.2M

854K

195K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $428M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Janney Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Janney Capital Management LLC with notifications on news.